- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05273879
Necessity of Fusion Following Decompression Surgery in Patients With Single-level Lumbar Stenosis
Necessity of Fusion Following Decompression Surgery in Patients With Single-level Lumbar Stenosis: Study Protocol for an Open-label Multicenter Non-inferiority Randomized Controlled Clinical Trial
Long-term clinical results of two methods of surgical treatment (spinal decompression with or without fusion) in patients with single-level lumbar stenosis will be compared. A clear framework for surgical treatment methods and standardized postoperative rehabilitation treatment will be set to obtain the maximum homogeneity of the patient groups.
This trial should provide the first level of evidence for the need for spinal fusion in patients with single-level lumbar stenosis, subject to the high homogeneous comparison groups. Additional results will allow comparing the economic aspects of different surgical treatments for 2 years after surgery.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The necessity of spinal segment fusion after decompression is one of the most controversial and unresolved issues in single-level lumbar spinal stenosis surgery. To date, only one trial carried out 15 years ago focused on this problem. The key purpose of the current trial is to compare the long-term clinical results of the two surgical methods (decompression vs. decompression and fusion) in patients with single-level lumbar stenosis.
This study is focused on the non-inferior clinical results of decompression compared with the standard fusion procedure. In the decompression group, the spinous process, the interspinous and supraspinous ligaments, part of the facet joints, and corresponding parts of the vertebral arch are to be preserved intact. In the fusion group, decompression is to be supplemented with transforaminal interbody fusion. Participants meeting the inclusion criteria will be randomly divided into two equal groups (1:1), depending on the surgical method. The final analysis will include 86 patients (43 per group). The primary endpoint is Oswestry Disability Index dynamics at the end of the 24-month follow-up compared to the baseline level. Secondary outcomes included those estimated using the SF-36 scale, EQ-5D-5L, and psychological scales. Additional parameters will include sagittal balance of the spine, fusion results, total cost of surgery, and hospital stay followed by two-year treatment. Follow-up examinations will be performed at 3, 6, 12, and 24 months Authors suggest that this study will improve the evidence for application of various surgical techniques for lumbar spine stenosis surgery and verify the existing protocol for surgical management.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ivan Lvov, MD, PhD
- Phone Number: +79265760074
- Email: dr.speleolog@gmail.com
Study Contact Backup
- Name: Anton Kordonskiy, MD, PhD
- Phone Number: +79265724547
- Email: akord.neuro@mail.ru
Study Locations
-
-
-
Moscow, Russian Federation, 105203
- Pirogov National Medical and Surgical Center
-
Moscow, Russian Federation, 107045
- Sklifosovsky Research Institute for Emergency Medicine
-
Moscow, Russian Federation, 105203
- Federal State Budgetary Institution "Federal Center for Brain and Neurotechnologies" FMBA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age of patients from 45 to 75 years;
- stenosis C or D according to Shizas et al. according to MRI at the level of L2-L3, L3-L4, L4-L5 or L5-S1;
- clinical manifestations of lumbar stenosis (neurogenic claudication syndrome and/or radiculopathy);
- lack of effect from conservative therapy within 3 months;
- Informed consent to take part in the study.
Exclusion Criteria:
- spondylolisthesis more than 3 mm;
- spinal instability according to functional radiography;
- sagittal imbalance (type 4 according to C. Barrey);
- bone density of the vertebrae at the level of the operation is less than 100 HU;
- clinically significant spinal stenosis at 2 or more levels;
- previously performed surgeries on the spine;
- risk of anesthesia 4 or 5 according to ASA;
- inability to take part in control examinations within 2 years after the operation;
- participation in other clinical trials related to surgical or conservative treatment of diseases of the spine.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: decompression group
minimally invasive decompression without fusion
|
laminotomy of the corresponding adjacent vertebrae, partial flavectomy and medial facetectomy are planned to be performed unilaterally.
Depending on the surgeon's personal preferences, the following two options are available: 1) equivalent decompression procedure contralaterally and 2) crossover contralateral decompression.
Irrespective of the selected option, the spinous process, the interspinous and supraspinous ligaments, part of the facet joints, and the corresponding part of the vertebral arch must be preserved intact in all participants.
|
Other: fusion group
minimally invasive decompression with trans-foraminal interbody fusion
|
First, decompression is performed according to one of the above methods.
Next, trans-foraminal interbody fusion with a cage (TLIF) and fixation with pedicle screws are performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oswestry Disability Index
Time Frame: 24 months
|
The questionnaire includes 10 sections containing 6 statements each.
Depending on the answer, a score is assigned (from 0 to 5).
The maximum number of points is 50.
After that, the points are converted into percentages (from 0 to 100%).
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SF-36 v.1 scale (standard form)
Time Frame: 24 months
|
The questionnaire contains 36 questions, grouped into 8 scales that assess physical functioning, role-playing, bodily pain, general health, vitality, social functioning, emotional state, and mental health.
For each of them, the maximum score is 100 points.
|
24 months
|
EQ-5D-5L
Time Frame: 24 months
|
The questionnaire contains 5 sections (mobility, self-care, usual activities, pain, anxiety) of three statements and the EQ-VAS visual analog pain scale.
The results can be converted into a single numerical value (index) adjusted for the patient's region of residence
|
24 months
|
Won-Korff Chronic Pain Syndrome Assessment Scale
Time Frame: 24 months
|
allows evaluating the severity of pain and its impact on life in points.
Grade 0 corresponds to the absence of pain, and grade IV to the maximum limitation of life because of severe pain.
|
24 months
|
Pain Catastrophizing Scale
Time Frame: 24 months
|
makes it possible to assess completely the psychological aspects of pain perception, in particular the exaggerated negative perception of painful stimuli.
The questionnaire contains 13 questions, each of which is evaluated in points (0 points, no symptom, 4, the patient experiences these feelings all the time).
|
24 months
|
Chronic Pain Coping Inventory
Time Frame: 24 months
|
allow one of eight scales to classify a patient's preferred strategy for coping with chronic pain.
|
24 months
|
scale of the American Society of Anesthesiologists ASA
Time Frame: baseline
|
This classification distinguishes 5 classes of physical status depending on the presence of concomitant diseases (Class I, healthy patient, Class V, dying).
|
baseline
|
The cost of the treatment
Time Frame: 24 months
|
The cost of hospitalization of the patient, including the performance of surgical intervention, as well as the period of the patient's incapacity for work because of spinal disease, will also be calculated.
Also, within 2 years after the intervention, the cost of subsequent treatment in rehabilitation centers and other hospitals for complications of the operation or other manifestations of degenerative-dystrophic changes in the lumbar spine will be considered.
|
24 months
|
quality of fusion
Time Frame: 24 months
|
according to CT data, the quality of fusion using the Tan criteria will be graded into one of four grades of fusion-grade I (complete fusion) to grade IV (bipolar pseudarthrosis)
|
24 months
|
pelvic tilt (PT)
Time Frame: 24 months
|
a parameter defined as the angle created by a line running from the sacral endplate midpoint to the center of the bifemoral heads and the vertical axis.
Will be evaluated on X-ray.
|
24 months
|
pelvic incidence (PI)
Time Frame: 24 months
|
the angle between the line perpendicular to the sacral endplate at its midpoint and a line connecting this point to the axis of the femoral head.
Will be evaluated on X-ray.
|
24 months
|
sacral slope (SS)
Time Frame: 24 months
|
the angle between the tangent line to the superior endplate of S1 and the horizontal plane.
Will be evaluated on X-ray.
|
24 months
|
al axis displacement (SVA)
Time Frame: 24 months
|
a horizontal distance between a plumb line dropped from the center of the C7 body and the posterior-superior corner of the S1 body.
Will be evaluated on X-ray.
|
24 months
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Andrey Grin, MD, PhD, Sklifosovsky Research Institute for Emergency Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 03\2022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Spinal Stenosis
-
Johns Hopkins UniversityNorth American Spine SocietyCompletedLumbar Spinal Stenosis | Lumbar Spine Degeneration | Lumbar Spinal InstabilityUnited States
-
Azienda Usl di BolognaRecruitingLumbar Spinal Stenosis | Degenerative Lumbar Spinal StenosisItaly
-
Medipol UniversityWithdrawnLumbar Spinal Stenosis | Lumbar Disc Disease | Lumbar Spine Degeneration | Lumbar Spine InstabilityTurkey
-
University Hospital, Basel, SwitzerlandKlinik für Radiologie und Nuklearmedizin, University Hospital BaselCompletedLumbar Spinal Stenosis | Symptomatic Lumbar Spinal StenosisSwitzerland
-
Bursa City HospitalCompletedLumbar Spinal Stenosis | Lumbar Spine Degeneration | Lumbar Spine InstabilityTurkey
-
Xuanwu Hospital, BeijingRecruitingLumbar Disc Herniation | Lumbar Spinal Stenosis | Lumbar SpondylosisChina
-
Neurocenter of Southern SwitzerlandMaastricht University; Schulthess KlinikRecruitingLumbar Spinal Stenosis | Lumbar Spondylolisthesis | Spinal Disease | Lumbar InstabilitySwitzerland
-
University of Roma La SapienzaRecruitingLumbar Spinal Stenosis | Lumbar Spondylolisthesis | Lumbar Spine Degeneration | Lumbar Spine InstabilityItaly
-
Cantonal Hospital of St. GallenProf. Dr. Astrid Weyerbrock, Klinik für Neurochirurgie, Kantonsspital St.... and other collaboratorsCompletedLumbar Spinal Stenosis | Lumbar Disc Disease | Lumbar Spine DegenerationSwitzerland
-
Kyungpook National University HospitalCompletedDisk Herniated Lumbar | Spinal Stenosis LumbarKorea, Republic of
Clinical Trials on fusion
-
The London Spine CentreUnknownSpinal Stenosis | Degenerative SpondylolisthesisCanada
-
Duke UniversityWithdrawnSurgery | Degenerative Disc Disease | Cervical Spine Disc Disease | Fusion of Spine
-
Olympus Biotech CorporationCompleted
-
Qianfoshan HospitalEnrolling by invitationLumbar Degenerative DiseaseChina
-
Twin Cities Spine CenterNot yet recruitingLumbar Spondylolisthesis | Spine Fusion | Lumbar StenosisUnited States
-
Rabin Medical CenterUnknown
-
Foundation for Orthopaedic Research and EducationCoreLink, LLCCompletedDegenerative Disc Disease Lumbar
-
Focal Healthcare Inc.Unknown
-
AOSpine North America Research NetworkCompletedIsthmic SpondylolisthesisUnited States, Canada